BioSpace News Archive

Porosimeter is an instrument that is used to determine the volume and diameter of pores. Additionally, it helps measure the distribution of pore volume of a porous substance.

The PCR and Real-time PCR Molecular Diagnostics Market survey presents a comprehensive overview of growth trajectory exhibited across key segments, including types and processing method.

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported that the Company will, on or around July 27, 2021, issue 1,000,000,000 additional registered shares out of the authorized share capital approved by the Annual General Meeting on June 18, 2021.

A national research study has just launched to investigate the effectiveness and safety of COVID-19 vaccines in transplant recipients.

ImmPACT Bio USA, Inc., a company developing novel cell therapies for treating cancer, announced its merger with Kalthera, Inc., a biotechnology company.

Medical Microinstruments SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced the University Hospital Salzburg, part of the Salzburg State Hospitals, is the world’s first hospital to implement the Symani® Surgical System for commercial use in its robotic microsurgery programs.

Danaher Corporation announced results for the second quarter 2021. All results in this release reflect only continuing operations unless otherwise noted.

Evelo Biosciences, a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, July 29, 2021, to report its second quarter 2021 financial results and discuss business highlights.

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced that it plans to release 2021 second quarter financial and operating results after the market closes on Thursday, August 5, 2021.

BioCryst Pharmaceuticals, Inc. announced that the company will report its second quarter 2021 financial results on Thursday, August 5, 2021.